0000899243-18-020110.txt : 20180718
0000899243-18-020110.hdr.sgml : 20180718
20180718173846
ACCESSION NUMBER: 0000899243-18-020110
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180718
FILED AS OF DATE: 20180718
DATE AS OF CHANGE: 20180718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Capital, LLC
CENTRAL INDEX KEY: 0001534261
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38584
FILM NUMBER: 18959109
BUSINESS ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2405
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212.300.5575
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2405
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Partners Master Fund, L.P.
CENTRAL INDEX KEY: 0001534265
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38584
FILM NUMBER: 18959110
BUSINESS ADDRESS:
STREET 1: WALKER HOUSE
STREET 2: 87 MARY STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: KY1-9001
BUSINESS PHONE: 212.300.5575
MAIL ADDRESS:
STREET 1: WALKER HOUSE
STREET 2: 87 MARY STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: KY1-9001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Partners GP, LLC
CENTRAL INDEX KEY: 0001534260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38584
FILM NUMBER: 18959111
BUSINESS ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 1140
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212.300.5575
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 1140
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Eli
CENTRAL INDEX KEY: 0001534264
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38584
FILM NUMBER: 18959112
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 1140
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Venture Opportunities Fund, L.P.
CENTRAL INDEX KEY: 0001730779
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38584
FILM NUMBER: 18959113
BUSINESS ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2405
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (212) 897-4930
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2405
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CASDIN VENTURE OPPORTUNITIES FUND GP, LLC
CENTRAL INDEX KEY: 0001746899
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38584
FILM NUMBER: 18959114
BUSINESS ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2405
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-897-5438
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2405
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001434418
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-714-0555
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2018-07-18
0
0001434418
CONSTELLATION PHARMACEUTICALS INC
CNST
0001534261
Casdin Capital, LLC
1350 AVENUE OF THE AMERICAS, SUITE 2405
NEW YORK
NY
10019
0
0
1
0
0001534265
Casdin Partners Master Fund, L.P.
C/O CASDIN CAPITAL LLC
1350 AVENUE OF THE AMERICAS, SUITE 1140
NEW YORK
NY
10019
0
0
1
0
0001534260
Casdin Partners GP, LLC
C/O CASDIN CAPITAL LLC
1350 AVENUE OF THE AMERICAS, SUITE 2405
NEW YORK
NY
10019
0
0
1
0
0001534264
Casdin Eli
C/O CASDIN CAPITAL LLC
1350 AVENUE OF THE AMERICAS, SUITE 2405
NEW YORK
NY
10019
0
0
1
0
0001730779
Casdin Venture Opportunities Fund, L.P.
C/O CASDIN CAPITAL LLC
1350 AVENUE OF THE AMERICAS, SUITE 2405
1350 AVENUE OF THE AMERICAS, S
NY
10019
0
0
1
0
0001746899
CASDIN VENTURE OPPORTUNITIES FUND GP, LLC
C/O CASDIN CAPITAL LLC
1350 AVENUE OF THE AMERICAS, SUITE 2405
NEW YORK
NY
10019
0
0
1
0
Series E Preferred Stock
Common Stock
155716
I
See Footnote
Series E-1 Preferred Stock
Common Stock
31104
I
See Footnote
Series F Preferred Stock
Common Stock
158963
I
See Footnote
Series F Preferred Stock
Common Stock
158960
I
See Footnote
The Series E Preferred Stock is convertible into Common Stock on a 8.56256-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
These securities are owned directly by Casdin Partners Master Fund, LP and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Partners Master Fund, LP, (ii) Casdin Partners GP, LLC, the general partner of Casdin Partners Master Fund LP, and (ii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.
The Series E-1 Preferred Stock is convertible into Common Stock on a 11.009-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
The Series F Preferred Stock is convertible into Common Stock on a 11.009-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
These securities are owned directly by Casdin Venture Opportunities Fund, LP and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Venture Opportunities Fund, LP, (ii) Casdin Venture Opportunities Fund GP, LLC, the general partner of Casdin Venture Opportunities Fund, LP, and (ii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Venture Opportunities Fund GP, LLC.
Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 3 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Casdin Capital, LLC, By: Eli Casdin, Managing Member, /s/ Eli Casdin
2018-07-18
Casdin Partners Master Fund, LP, By: Casdin Partners GP, LLC, General Partner, By: Eli Casdin, Managing Member, /s/ Eli Casdin
2018-07-18
Casdin Partners GP, LLC, By: Eli Casdin, Managing Member, /s/ Eli Casdin
2018-07-18
Eli Casdin, /s/ Eli Casdin
2018-07-18
Casdin Venture Opportunities Fund, LP, Casdin Venture Opportunities Fund GP, LLC, General Partner, By: Eli Casdin, Managing Member, /s/ Eli Casdin
2018-07-18
Casdin Venture Opportunities Fund GP, LLC, By: Eli Casdin, Managing Member, /s/ Eli Casdin
2018-07-18